Importantly, inhibiting TAK1 reduced collagen gene expressions, myofibroblast differentiation, and production of the endogenous TLR4 ligands DAMP Fn-EDA and tenascin C in SSc skin fibroblasts. This evidence concerns the gene FN1 and systemic sclerosis.